Delia
D'Avola
Consultora Médica
Alberto
Benito Boillos
Consultor Médico
Alberto Benito Boillos-rekin lankidetzan egindako argitalpenak (11)
2016
-
Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria
Journal of Hepatology, Vol. 65, Núm. 4, pp. 776-783
-
Recombinant AAV Integration Is Not Associated with Hepatic Genotoxicity in Nonhuman Primates and Patients
Molecular Therapy, Vol. 24, Núm. 6, pp. 1100-1105
2015
-
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma
Liver International, Vol. 35, Núm. 6, pp. 1715-1721
2014
-
Is liver biopsy necessary in the evaluation of a living donor for liver transplantation?
Transplantation Proceedings
-
Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension
HPB, Vol. 16, Núm. 3, pp. 243-249
2013
-
Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma
Journal of Hepatology, Vol. 59, Núm. 4, pp. 753-761
-
Prognostic factors and prevention of radioembolization-induced liver disease
Hepatology, Vol. 57, Núm. 3, pp. 1078-1087
-
Safety and liver transduction efficacy of raav5-cohpbgd in nonhuman primates: A potential therapy for acute intermittent porphyria
Human Gene Therapy, Vol. 24, Núm. 12, pp. 1007-1017
2012
-
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma
European Journal of Surgical Oncology, Vol. 38, Núm. 7, pp. 594-601
2011
-
Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages
Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971
2010
-
Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma
International Journal of Radiation Oncology Biology Physics, Vol. 77, Núm. 5, pp. 1441-1448